UAB "Nordclinic Group" Finance - revenue, profit
EBITDA margin (%)
Register and
explore Okredo dataEBIT margin (%)
Register and
explore Okredo data| Indicator |
|---|
| Turnover (€) |
| Sales per employee (€) |
| Profit before tax (€) |
| Net Profit (€) |
| Profit per employee (€) |
| Total profitability (%) |
| Net profitability (%) |
| Equity (€) |
| Amounts Payable And Liabilities (€) |
| Non-current Assets (€) |
| CurrentAssets (€) |
| Working capital requirement |
| Debt-to-equity ratio |
| EBITDA margin (%) |
| EBITDA (€) |
| EBIT margin (%) |
| EBIT (€) |
| 2022 |
|---|
| 18,325,543 |
| 59,576 |
| 516,900 |
| 516,900 |
| 1,680 |
| 70.57 |
| 2.82 |
| 1,391,688 |
| 5,080,603 |
| 1,894,389 |
| 4,599,987 |
| 0.03 |
| 3.65 |
| 3.26 |
| 597,709 |
| 2.93 |
| 537,615 |
| 2023 |
|---|
| 19,437,649 |
| 57,426 |
| -371,135 |
| -371,135 |
| -1,096 |
| 36.04 |
| -1.91 |
| 595,062 |
| 4,596,019 |
| 1,796,734 |
| 3,384,083 |
| -0.03 |
| 7.72 |
| 0.91 |
| 177,026 |
| 0.44 |
| 86,054 |
| 2024 |
|---|
| 23,865,167 |
| 66,197 |
| 251,690 |
| 251,690 |
| 698 |
| 37.04 |
| 1.05 |
| 846,752 |
| 7,190,208 |
| 6,422,667 |
| 1,655,948 |
| -0.10 |
| 8.49 |
| 2.75 |
| 655,375 |
| 2.08 |
| 496,127 |
| 2024 |
|---|
| 23,865,167 |
| 66,197 |
| 251,690 |
| 251,690 |
| 698 |
| 37.04 |
| 1.05 |
| 846,752 |
| 7,190,208 |
| 6,422,667 |
| 1,655,948 |
| -0.10 |
| 8.49 |
| 2.75 |
| 655,375 |
| 2.08 |
| 496,127 |
Turnover (€)
2024
Turnover (€)
23,865,167 €23 % *
Sales per employee (€)
66,197 €15 % *
Profit before tax (€)
251,690 €168 % *
Net Profit (€)
251,690 €168 % *
Profit per employee (€)
698 €164 % *
Total profitability (%)
37.04 %2.77 % *
Net profitability (%)
1.05 %154.97 % *
Equity (€)
846,752 €42 % *
Amounts Payable And Liabilities (€)
7,190,208 €56 % *
Non-current Assets (€)
6,422,667 €257 % *
CurrentAssets (€)
1,655,948 €-51 % *
Working capital requirement
-0.10 -233.33 % *
Debt-to-equity ratio
8.49 9.97 % *
EBITDA margin (%)
2.75 %202.20 % *
EBITDA (€)
655,375 €270 % *
EBIT margin (%)
2.08 %372.73 % *
EBIT (€)
496,127 €477 % *
